Integer Holdings Corporation (NYSE: ITGR) is a Healthcare company (Medical - Devices) with a market capitalization of $4.3B. The Maz Rating grades it against the other companies in its sector.
Integer Holdings Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $126.97, Integer Holdings Corporation trades at 42.3x trailing earnings, 2.4x sales and 2.5x book value, with an EV/EBITDA of 19.7. Over the last twelve months it generated about $1.8B of revenue and $102M of net income. It runs a gross margin of 23.6%, an operating margin of 8.2% and a net margin of 5.7%. It shows return on equity of 6.0%, return on invested capital of 4.5% and a free cash flow yield of 1.9%. On the balance sheet: a debt-to-equity ratio of 0.78 and a current ratio of 3.98. Over the past 52 weeks the share price ranged from $66.51 to $133.06, with a beta of 0.58.
Integer Holdings Corporation does not currently pay a dividend.
16 Wall Street analyst ratings cover the stock: 8 Buy and 8 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of October 2026, Integer Holdings Corporation (ITGR) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 28.4% / 30% · (Cash+Inv) / Mkt Cap (36m) 0.33% / 30% · Interest income / Revenue 0.00% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 28.4% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 0.33% / 33% · Receivables / Mkt Cap (36m) 8.04% / 49% · Interest income / Revenue 0.00% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 28.4% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 0.33% / 33.33% · Receivables / Mkt Cap (24m) 8.04% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 36.8% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 0.45% / 33.33% · Receivables / Avg Assets (4Q) 9.95% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| FTSE | Debt / Total Assets 35.9% / 33.33% · (Cash+ST Inv) / Total Assets 0.42% / 33.33% · (Cash+Recv) / Total Assets 10.6% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
It depends on the standard you follow. As of October 2026, Integer Holdings Corporation (ITGR) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
Yes. Integer Holdings Corporation is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
Integer Holdings Corporation reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated October 2, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.